HeadInvest LLC’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,307
Closed -$201K 250
2024
Q3
$201K Buy
+1,307
New +$198K 0.04% 236
2023
Q4
Sell
-1,502
Closed -$193K 722
2023
Q3
$193K Hold
1,502
0.04% 222
2023
Q2
$204K Sell
1,502
-532
-26% -$70.1K 0.04% 222
2023
Q1
$263K Buy
2,034
+75
+4% +$9.8K 0.06% 190
2022
Q4
$266K Sell
1,959
-60
-3% -$7.95K 0.06% 189
2022
Q3
$245K Hold
2,019
0.06% 190
2022
Q2
$259K Sell
2,019
-95
-4% -$12.5K 0.06% 188
2022
Q1
$290K Hold
2,114
0.06% 193
2021
Q4
$298K Hold
2,114
0.05% 195
2021
Q3
$269K Sell
2,114
-254
-11% -$33.6K 0.05% 196
2021
Q2
$298K Hold
2,368
0.06% 189
2021
Q1
$276K Hold
2,368
0.06% 189
2020
Q4
$269K Hold
2,368
0.06% 178
2020
Q3
$250K Buy
2,368
+90
+4% +$9.47K 0.07% 160
2020
Q2
$228K Buy
+2,278
New +$225K 0.07% 163
2020
Q1
Sell
-1,983
Closed -$202K 188
2019
Q4
$202K Buy
+1,983
New +$191K 0.06% 194

Other funds holding XLV

HeadInvest LLC's XLV Position: Q4 2024 in Review

HeadInvest LLC sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q4 2024, closing a stake of 1,307 shares — an estimated $201K sold.

HeadInvest LLC first reported a position in XLV in Q4 2019 and held it in 16 quarters. The position peaked at $298K in Q4 2021. 1,759 funds tracked by Wall St. Rank hold XLV as of Q4 2024.

  • HeadInvest LLC reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q4 2024 after selling out during the quarter.
  • HeadInvest LLC sold 1,307 State Street Health Care Select Sector SPDR ETF shares in Q4 2024, an estimated $201K.
  • HeadInvest LLC first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2019 and held it in 16 quarters.
  • HeadInvest LLC's State Street Health Care Select Sector SPDR ETF position peaked at $298K in Q4 2021.
  • 1,759 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q4 2024.

Based on HeadInvest LLC's 13F filing for Q4 2024, filed 18 Feb 2025.